Firm at a glance
Clearlake Capital is a platform private equity firm founded in 2006 with offices in Santa Monica, London, Dublin, and Singapore, per its own website [S1].
What they buy
Clearlake’s public portfolio reflects activity across technology, healthcare, industrials, and consumer sectors [S2]. The firm’s disclosed holdings include software businesses such as Quest Software and Precisely, healthcare technology platforms including symplr and ModMed, industrial services provider United Site Services, and consumer company BakeMark [S2]. Recent transactions indicate continued focus on technology and healthcare software platforms with add-on acquisition strategies [S3][S4][S5].
Portfolio
Technology
Quest Software and Precisely [S2]
Healthcare
symplr and ModMed [S2]
Industrials
United Site Services [S2]
Consumer
BakeMark [S2]
Recent activity (last 24 months)
– June 2026: Closed CCP VIII fund at $14.8 billion [S3]
– June 2026: Quest Software acquired Anetac to expand identity security capabilities [S5]
– June 2026: Completed acquisition of Pathway Capital Management [S6]
– April 2026: Completed acquisition of Qualus [S7]
– April 2026: Portfolio company ModMed acquired Bonsai Health as an add-on [S4]
How this firm fits a seller
Clearlake appears to pursue a buy-and-build strategy, evidenced by two add-on acquisitions in the trailing twelve months across its technology and healthcare platforms [S4][S5]. The firm reported approximately $185 billion in assets under management as of July 2026 [S1], suggesting capacity for larger platform investments. For sellers in technology or healthcare software, Clearlake’s recent activity indicates appetite for both platform acquisitions and strategic add-ons to existing portfolio companies. The 2026 fund close suggests active deployment capital [S3].
Sources
[S1] https://clearlake.com/about/ (as of 2026-07-14)
[S2] https://clearlake.com/portfolio/ (as of 2026-07-14)
[S3] https://clearlake.com/news/clearlake-capital-closes-on-148-billion-to-capitalize-on-ai-driven-transformation-and-continue-sector-focused-investment-strategy (as of 2026-06-16)
[S4] https://clearlake.com/news/modmed-acquires-bonsai-health-to-accelerate-ai-powered-patient-engagement (as of 2026-04-20)
[S5] https://clearlake.com/news/clearlake-backed-quest-software-acquires-anetac-to-advance-identity-security-for-the-agentic-ai-era (as of 2026-06-17)
[S6] https://clearlake.com/news/clearlake-completes-strategic-acquisition-of-pathway-capital-management (as of 2026-06-09)
[S7] https://clearlake.com/news/clearlake-completes-acquisition-of-qualus (as of 2026-04-30)
Frequently asked questions
Does Clearlake Capital buy technology businesses?
Yes, technology represents a visible sector focus based on public portfolio holdings. Clearlake’s disclosed technology investments include Quest Software and Precisely [S2], and the firm completed an add-on acquisition for Quest Software in June 2026 [S5].
What companies has Clearlake Capital acquired recently?
Recent disclosed transactions include the acquisition of Qualus in April 2026 [S7] and Pathway Capital Management in June 2026 [S6]. Portfolio company ModMed acquired Bonsai Health as an add-on in April 2026 [S4].
Where is Clearlake Capital based and how big is the firm?
Clearlake maintains offices in Santa Monica, London, Dublin, and Singapore [S1]. The firm reported approximately $185 billion in assets under management as of July 2026 [S1].
Is Clearlake Capital still actively acquiring?
Yes, Clearlake completed multiple transactions in 2026, including two platform acquisitions and two add-on deals through portfolio companies, with the most recent activity in June 2026 [S3][S5][S6][S7]. The firm closed a $14.8 billion fund in June 2026 [S3].
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.